Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Georgi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|August 25, 2019
Considerations for improved performance of competition association assays analysed with the Motulsky-Mahan's "kinetics of competitive binding" modelVictoria Georgi, Alexey Dubrovskiy, Stephan Steigele, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Binding kinetics in drug discovery - A current perspectiveVictoria Georgi, Dorothee Andres, Amaury E Fernandez-Montalvan, et al.
British Journal of Pharmacology|September 24, 2015
Characterization of 12 GnRH peptide agonists - a kinetic perspectiveIndira Nederpelt, Victoria Georgi, Felix Schiele, et al.
Angewandte Chemie (International Ed. in English)|March 31, 2018
Halogen-Aromatic π Interactions Modulate Inhibitor Residence TimesChristina Heroven, Victoria Georgi, Gaurav K Ganotra, et al.
Scientific Reports|January 19, 2024
A miniaturized mode-of-action profiling platform enables high throughput characterization of the molecular and cellular dynamics of EZH2 inhibitionLilia Falkenstern, Victoria Georgi, Stefanie Bunse, et al.
Journal of the American Chemical Society|October 27, 2018
Binding Kinetics Survey of the Drugged KinomeVictoria Georgi, Felix Schiele, Benedict-Tilman Berger, et al.
Scientific Reports|May 29, 2019
Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptorReggie Bosma, Leigh A Stoddart, Victoria Georgi, et al.
British Journal of Pharmacology|July 28, 2018
In vitro and in silico analysis of the effects of D<sub>2</sub> receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrationsWilhelmus E A de Witte, Joost W Versfelt, Maria Kuzikov, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
Drug Discovery Today|April 17, 2017
Kinetics for Drug Discovery: an industry-driven effort to target drug residence timeDoris A Schuetz, Wilhelmus Egbertus Arnout de Witte, Yin Cheong Wong, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|August 25, 2019
Considerations for improved performance of competition association assays analysed with the Motulsky-Mahan's "kinetics of competitive binding" modelVictoria Georgi, Alexey Dubrovskiy, Stephan Steigele, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Binding kinetics in drug discovery - A current perspectiveVictoria Georgi, Dorothee Andres, Amaury E Fernandez-Montalvan, et al.
British Journal of Pharmacology|September 24, 2015
Characterization of 12 GnRH peptide agonists - a kinetic perspectiveIndira Nederpelt, Victoria Georgi, Felix Schiele, et al.
Angewandte Chemie (International Ed. in English)|March 31, 2018
Halogen-Aromatic π Interactions Modulate Inhibitor Residence TimesChristina Heroven, Victoria Georgi, Gaurav K Ganotra, et al.
Scientific Reports|January 19, 2024
A miniaturized mode-of-action profiling platform enables high throughput characterization of the molecular and cellular dynamics of EZH2 inhibitionLilia Falkenstern, Victoria Georgi, Stefanie Bunse, et al.
Journal of the American Chemical Society|October 27, 2018
Binding Kinetics Survey of the Drugged KinomeVictoria Georgi, Felix Schiele, Benedict-Tilman Berger, et al.
Scientific Reports|May 29, 2019
Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptorReggie Bosma, Leigh A Stoddart, Victoria Georgi, et al.
British Journal of Pharmacology|July 28, 2018
In vitro and in silico analysis of the effects of D<sub>2</sub> receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrationsWilhelmus E A de Witte, Joost W Versfelt, Maria Kuzikov, et al.
Molecular Oncology|January 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosisTatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller, et al.
Drug Discovery Today|April 17, 2017
Kinetics for Drug Discovery: an industry-driven effort to target drug residence timeDoris A Schuetz, Wilhelmus Egbertus Arnout de Witte, Yin Cheong Wong, et al.
Pageof 1